Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
h decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
h decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14081
-
14082
Table_5_The Dual Role of AQP4 in Cytotoxic and Vasogenic Edema Following Spinal Cord Contusion and Its Possible Association With Energy Metabolism via COX5A.XLSX
Published 2019“…Meanwhile, AQP4 and COX5A are detected by real-time quantitative PCR (qRT-PCR) and western blot (WB). …”
-
14083
EFFECT OF THE P.A.R.Q.V.E ON RHIZARTHRITIS
Published 2018“…Palmar grip improvement was affected by age and presence of rhizarthritis (p<0.05); patients with unilateral rhizarthritis improved 5.3 times more than patients without the disease (p=0.015), while improvement in palmar grip strength decreased 6.8% per year (p=0.004). …”
-
14084
EphrinA5 isoforms suppress cell proliferation and migration.
Published 2012“…Ectopic expression of ephrinA5 significantly decreased the cell migratory ability of both cell types. …”
-
14085
-
14086
-
14087
Schematic representation of possible mechanism of action of OKN-007 in IC3752 pGBM tumor bearing mice.
Published 2015“…By removing 6-O-sulfates on HS chains and mobilizing protein ligands from HSPG sequestration in the extracellular environment (3), the SULF-2 can increase the solubility of a variety of growth factors (e.g. PDGF) (4) thus increasing the activation of PDGFR-α and downstream signaling pathways in tumor cells (5) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0134276#pone.0134276.ref098" target="_blank">98</a>]. …”
-
14088
(A) The proportion of fast MyHC myotubes is decreased in Igf-2 deficient mice (maternal disomy Chromosome 7 - MatDi) at E14
Published 2011“…(B) Embryo immunoblotting for Igf-2 demonstrates a stage related increase in Igf-2 protein between E10.5 and E15.5 in WT and absence of Igf-2 in MatDi embryos at E14.5 and E15.5 Tracks 1–4 E10.5, E13.5, E14.5 and E15.5 WT embryos respectively, Track 5 E14.5 MatDi, Track 6 E15.5 MatDi and Track 7 E15.5 WT. …”
-
14089
-
14090
-
14091
-
14092
Adaptation of <i>B</i>. <i>subtilis</i> Rho<sup>+</sup> cells to a sudden nutrient downshift.
Published 2023“…<i>subtilis</i> WT, Rho<sup>+</sup> and their respective derivative strains carrying <i>guaB</i>S121F and <i>guaB</i>T139I mutations were cultivated in liquid S7 medium containing 0.5% (w/v) of CAA and tested for the ability to grow in the absence of CAA as in (A). …”
-
14093
-
14094
-
14095
-
14096
-
14097
Baseline characteristics of the patients<sup>a</sup>.
Published 2024“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log<sub>10</sub> within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”
-
14098
-
14099
-
14100